We recently published 12 Stocks on Jim Cramer’s Radar. Pfizer Inc. (NYSE:PFE) is one of the stocks on Jim Cramer's radar.
Pfizer Inc. (NYSE:PFE)’s shares are down by 5.90% year-to-date, and December has been a tumultuous month for them. On Tuesday, the stock dipped by 5.2% after the firm released its full-year 2026 guidance. The figures saw Pfizer Inc. (NYSE:PFE) forecast 2026 revenue to range between $59.5 billion to $62.5 billion and profit per share between $2.80 and $3. Both of these were below LSEG estimates. A key focus of the latest financial figures from Pfizer Inc. (NYSE:PFE) was the firm’s COVID-19 vaccine revenue as it shared that these sales would be $1.5 billion lower in 2026 over 2025’s figures.
Time to Go Short on Pfizer (PFE)?
Ahead of the release, Morgan Stanley had maintained an Equal-Weight rating and cut Pfizer Inc. (NYSE:PFE)’s share price target to $28 from $32. On December 17th, the bank adjusted the share price target to $27. Yet, on the same day, BMO maintained its $30 price target and an Outperform rating on Pfizer Inc. (NYSE:PFE)’s shares. As part of the release, it cited optimism about Pfizer Inc. (NYSE:PFE)’s cost-saving plans and the Metsera acquisition.
Cramer is tilted towards the optimistic side for Pfizer Inc. (NYSE:PFE). In his previous comments about the firm, the CNBC TV host has pointed out that CEO Dr. Albert Bourla could share important details at the JPMorgan Healthcare conference in January. In this appearance, he insisted that the CEO had a good hand:
“Yeah, Dr. Bourla’s struggling, he’s struggling because I think he’s got a good hand.”
While we acknowledge the potential of PFE as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the best short-term AI stock.
READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.
Disclosure: None. This article is originally published at Insider Monkey.